Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib
<br><strong>Background </strong>Pain is a core domain of psoriatic arthritis (PsA). This post hoc analysis evaluated time to pain improvement and the impact of baseline pain severity on pain response in patients with PsA receiving tofacitinib. <br><strong> Methods </...
Main Authors: | de Vlam, K, Ogdie, A, Bushmakin, AG, Cappelleri, JC, Fleischmann, R, Taylor, PC, Azevedo, V, Fallon, L, Woolcott, J, Mease, PJ |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
BMJ Publishing Group
2021
|
Registos relacionados
-
Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib
Por: de Vlam, K, et al.
Publicado em: (2018) -
Baseline pain severity as a predictor of pain improvement following treatment with tofacitinib in psoriatic arthritis
Por: Ogdie, A, et al.
Publicado em: (2018) -
Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis
Por: de Vlam, K, et al.
Publicado em: (2022) -
Understanding mediators of pain reduction in psoriatic arthritis patients treated with tofacitinib: role of inflammation
Por: Taylor, P, et al.
Publicado em: (2019) -
Identifying mediators of pain reduction in patients with psoriatic arthritis treated with tofacitinib: Role of inflammation associated with peripheral arthritis, enthesitis and skin disease
Por: Taylor, PC, et al.
Publicado em: (2020)